Combination of antitumour necrosis factor-α and anti-interleukin-12/23 antibodies in refractory psoriasis and psoriatic arthritis: a long-term case-series observational study

Robert Gniadecki; B Bang; C Sand

doi:10.1111/bjd.14270

Combination of antitumour necrosis factor-α and anti-interleukin-12/23 antibodies in refractory psoriasis and psoriatic arthritis: a long-term case-series observational study

Robert Gniadecki, B Bang, C Sand

IKM

Publikation: Bidrag til tidsskrift › Letter › Forskning › peer review

28 Citationer (Scopus)

Originalsprog	Engelsk
Tidsskrift	British Journal of Dermatology
Vol/bind	174
Udgave nummer	5
Sider (fra-til)	1145-6
Antal sider	2
ISSN	0007-0963
DOI	https://doi.org/10.1111/bjd.14270
Status	Udgivet - maj 2016

Adgang til dokumentet

10.1111/bjd.14270

Citationsformater

@article{f73b3837eb1f4e7596b1fe534f204da3,

title = "Combination of antitumour necrosis factor-α and anti-interleukin-12/23 antibodies in refractory psoriasis and psoriatic arthritis: a long-term case-series observational study",

keywords = "Adalimumab, Adult, Aged, Antibodies, Monoclonal, Antibodies, Monoclonal, Humanized, Arthritis, Psoriatic, Certolizumab Pegol, Dermatologic Agents, Drug Resistance, Drug Therapy, Combination, Etanercept, Female, Humans, Interleukin-12, Interleukin-23, Male, Middle Aged, Psoriasis, Treatment Outcome, Tumor Necrosis Factor-alpha, Ustekinumab, Case Reports, Letter, Observational Study",

author = "Robert Gniadecki and B Bang and C Sand",

year = "2016",

month = may,

doi = "10.1111/bjd.14270",

language = "English",

volume = "174",

pages = "1145--6",

journal = "British Journal of Dermatology",

issn = "0007-0963",

publisher = "Wiley-Blackwell",

number = "5",

}

TY - JOUR

T1 - Combination of antitumour necrosis factor-α and anti-interleukin-12/23 antibodies in refractory psoriasis and psoriatic arthritis

T2 - a long-term case-series observational study

AU - Gniadecki, Robert

AU - Bang, B

AU - Sand, C

PY - 2016/5

Y1 - 2016/5

KW - Adalimumab

KW - Adult

KW - Aged

KW - Antibodies, Monoclonal

KW - Antibodies, Monoclonal, Humanized

KW - Arthritis, Psoriatic

KW - Certolizumab Pegol

KW - Dermatologic Agents

KW - Drug Resistance

KW - Drug Therapy, Combination

KW - Etanercept

KW - Female

KW - Humans

KW - Interleukin-12

KW - Interleukin-23

KW - Male

KW - Middle Aged

KW - Psoriasis

KW - Treatment Outcome

KW - Tumor Necrosis Factor-alpha

KW - Ustekinumab

KW - Case Reports

KW - Letter

KW - Observational Study

U2 - 10.1111/bjd.14270

DO - 10.1111/bjd.14270

M3 - Letter

C2 - 26522308

VL - 174

SP - 1145

EP - 1146

JO - British Journal of Dermatology

JF - British Journal of Dermatology

SN - 0007-0963

IS - 5

ER -